These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2698701)

  • 1. [Large trials in hypertension].
    Gouveia A
    Rev Port Cardiol; 1989 Apr; 8(4):283-7. PubMed ID: 2698701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical profile of arterial hypertension in patients with cerebrovascular diseases].
    García-Ortiz R; Misseroni S; Zolezzi J
    Rev Med Chil; 1993 Sep; 121(9):1017-23. PubMed ID: 8191151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease.
    Hebert PR; Moser M; Mayer J; Glynn RJ; Hennekens CH
    Arch Intern Med; 1993 Mar; 153(5):578-81. PubMed ID: 8439221
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertension in the elderly.
    McCoy CE
    R I Med; 1993 May; 76(5):239-42. PubMed ID: 8518499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension trial results: consensus and conflicts.
    Dollery C
    J Hum Hypertens; 1995 Jun; 9(6):403-8. PubMed ID: 7473518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-hemodynamic vascular risk in the patient with arterial hypertension. The effects of medical therapy].
    Magnani B; Rapezzi C
    Cardiologia; 1994 Dec; 39(12 Suppl 1):299-302. PubMed ID: 7634287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive therapy in stroke: acute therapy, primary and secondary prevention].
    Brainin M
    Acta Med Austriaca; 1995; 22(3):54-7. PubMed ID: 8571753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke in the elderly treated for systolic hypertension (SHEP).
    Singer RB
    J Insur Med; 1991; 23(4):265-9. PubMed ID: 10148513
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic trials in arterial hypertension].
    Gueyffier F
    Rev Prat; 1999 Mar; 49(5):512-8. PubMed ID: 10358401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of the benefits of treating arterial hypertension in the elderly].
    Castiella Herrero J
    Med Clin (Barc); 1993 Jun; 101(3):95-8. PubMed ID: 8315992
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of systolic blood pressure in determining risk for cardiovascular disease.
    Levy D
    J Hypertens Suppl; 1999 Feb; 17(1):S15-8. PubMed ID: 10340839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party.
    Medical Research Council Working Party
    Br Med J (Clin Res Ed); 1988 Jun; 296(6636):1565-70. PubMed ID: 3135010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risks of hypertension: lessons from observational studies.
    O'Donnell CJ; Kannel WB
    J Hypertens Suppl; 1998 Oct; 16(6):S3-7. PubMed ID: 9856377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postmenopausal arterial hypertension and cardiovascular risk].
    Artigao R
    Rev Esp Cardiol; 1998; 51 Suppl 4():36-43. PubMed ID: 9883067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits and risks of treating mild to moderate hypertension.
    Kawachi I; Purdie G
    N Z Med J; 1989 Jul; 102(872):377-9. PubMed ID: 2797555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].
    Castaigne A; Haziza F; Lopes-Darmon ME
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():59-63. PubMed ID: 9833081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and differential antihypertensive therapies.
    Os I
    Acta Med Austriaca; 1995; 22(3):45-7. PubMed ID: 8571750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.
    Gueyffier F; Froment A; Gouton M
    J Hum Hypertens; 1996 Jan; 10(1):1-8. PubMed ID: 8642184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjustment of the apparent benefits of treatment on stroke risk in the MRC mild hypertension trial using data from the placebo-treated group.
    Millar JA; Lever AF
    J Hum Hypertens; 1995 Jun; 9(6):409-12. PubMed ID: 7473519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular damage in hypertension.
    Strandgaard S; Paulson OB
    J Cardiovasc Risk; 1995 Feb; 2(1):34-9. PubMed ID: 7606637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.